Incyte Corporation

Healthcare

NASDAQ:INCY · NASDAQ Global Select

Market Cap $21.79B Beta 0.79 P/E (TTM) 15.2

$109.08 +1.16%

+$1.25 today

52W Low $66.74High $112.29

Vol 0.75M · Avg 1.54M

EPS (TTM)$7.18

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+60.94%

Period High

$110.57

Period Low

$67.26

Latest

$109.04

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Biogen Inc.

NASDAQ:BIIB

$29.58B

Illumina, Inc.

NASDAQ:ILMN

$24.47B

Royalty Pharma plc

NASDAQ:RPRX

$23.72B

West Pharmaceutical Services, Inc.

NYSE:WST

$23.28B

Waters Corporation

NYSE:WAT

$23.15B

United Therapeutics Corporation

NASDAQ:UTHR

$23.02B

Quest Diagnostics Incorporated

NYSE:DGX

$22.46B

Zimmer Biomet Holdings, Inc.

NYSE:ZBH

$17.13B

Genmab A/S

NASDAQ:GMAB

$15.37B

Tenet Healthcare Corporation

NYSE:THC

$15.25B

What is the latest INCY filing?

The latest filing shown is 4 dated Jun 10, 2026.

How many recent filings does INCY have?

Intrinsic Alpha currently shows 20 recent filings for INCY.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.